vs

Side-by-side financial comparison of KRONOS WORLDWIDE INC (KRO) and STEPAN CO (SCL). Click either name above to swap in a different company.

STEPAN CO is the larger business by last-quarter revenue ($604.5M vs $418.3M, roughly 1.4× KRONOS WORLDWIDE INC). STEPAN CO runs the higher net margin — 3.3% vs -19.8%, a 23.1% gap on every dollar of revenue. On growth, STEPAN CO posted the faster year-over-year revenue change (1.9% vs -1.1%). Over the past eight quarters, STEPAN CO's revenue compounded faster (4.2% CAGR vs -6.5%).

Kronos Incorporated was an American multinational workforce management and human capital management cloud provider headquartered in Lowell, Massachusetts, United States, which employed more than 6,000 people worldwide.

Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.

KRO vs SCL — Head-to-Head

Bigger by revenue
SCL
SCL
1.4× larger
SCL
$604.5M
$418.3M
KRO
Growing faster (revenue YoY)
SCL
SCL
+3.0% gap
SCL
1.9%
-1.1%
KRO
Higher net margin
SCL
SCL
23.1% more per $
SCL
3.3%
-19.8%
KRO
Faster 2-yr revenue CAGR
SCL
SCL
Annualised
SCL
4.2%
-6.5%
KRO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
KRO
KRO
SCL
SCL
Revenue
$418.3M
$604.5M
Net Profit
$-82.8M
$19.7M
Gross Margin
-0.9%
10.7%
Operating Margin
-15.1%
4.7%
Net Margin
-19.8%
3.3%
Revenue YoY
-1.1%
1.9%
Net Profit YoY
-527.3%
EPS (diluted)
$-0.72
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KRO
KRO
SCL
SCL
Q1 26
$604.5M
Q4 25
$418.3M
$553.9M
Q3 25
$456.9M
$590.3M
Q2 25
$494.4M
$594.7M
Q1 25
$489.8M
$593.3M
Q4 24
$423.1M
$525.6M
Q3 24
$484.7M
$546.8M
Q2 24
$500.5M
$556.4M
Net Profit
KRO
KRO
SCL
SCL
Q1 26
$19.7M
Q4 25
$-82.8M
$5.0M
Q3 25
$-37.0M
$10.8M
Q2 25
$-9.2M
$11.3M
Q1 25
$18.1M
$19.7M
Q4 24
$-13.2M
$3.4M
Q3 24
$71.8M
$23.6M
Q2 24
$19.5M
$9.5M
Gross Margin
KRO
KRO
SCL
SCL
Q1 26
10.7%
Q4 25
-0.9%
9.3%
Q3 25
10.3%
12.0%
Q2 25
12.7%
12.1%
Q1 25
21.8%
12.7%
Q4 24
20.4%
10.8%
Q3 24
20.9%
13.8%
Q2 24
20.0%
12.5%
Operating Margin
KRO
KRO
SCL
SCL
Q1 26
4.7%
Q4 25
-15.1%
1.9%
Q3 25
-4.2%
3.7%
Q2 25
1.5%
3.0%
Q1 25
7.8%
4.8%
Q4 24
6.8%
1.5%
Q3 24
8.0%
4.4%
Q2 24
7.2%
3.4%
Net Margin
KRO
KRO
SCL
SCL
Q1 26
3.3%
Q4 25
-19.8%
0.9%
Q3 25
-8.1%
1.8%
Q2 25
-1.9%
1.9%
Q1 25
3.7%
3.3%
Q4 24
-3.1%
0.6%
Q3 24
14.8%
4.3%
Q2 24
3.9%
1.7%
EPS (diluted)
KRO
KRO
SCL
SCL
Q1 26
$0.86
Q4 25
$-0.72
$0.22
Q3 25
$-0.32
$0.47
Q2 25
$-0.08
$0.50
Q1 25
$0.16
$0.86
Q4 24
$-0.11
$0.14
Q3 24
$0.62
$1.03
Q2 24
$0.17
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KRO
KRO
SCL
SCL
Cash + ST InvestmentsLiquidity on hand
$33.2M
Total DebtLower is stronger
$557.4M
$328.4M
Stockholders' EquityBook value
$751.1M
$1.2B
Total Assets
$1.8B
$2.3B
Debt / EquityLower = less leverage
0.74×
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KRO
KRO
SCL
SCL
Q1 26
Q4 25
$33.2M
$132.7M
Q3 25
$27.7M
$118.5M
Q2 25
$18.9M
$88.9M
Q1 25
$20.5M
$107.5M
Q4 24
$106.7M
$99.7M
Q3 24
$94.8M
$147.3M
Q2 24
$133.8M
$124.7M
Total Debt
KRO
KRO
SCL
SCL
Q1 26
$328.4M
Q4 25
$557.4M
$626.7M
Q3 25
$626.2M
$655.5M
Q2 25
$589.3M
$658.0M
Q1 25
$557.2M
$659.3M
Q4 24
$507.4M
$625.4M
Q3 24
$554.3M
$688.5M
Q2 24
$423.7M
$657.1M
Stockholders' Equity
KRO
KRO
SCL
SCL
Q1 26
$1.2B
Q4 25
$751.1M
$1.2B
Q3 25
$804.7M
$1.2B
Q2 25
$846.8M
$1.2B
Q1 25
$847.0M
$1.2B
Q4 24
$817.0M
$1.2B
Q3 24
$847.4M
$1.2B
Q2 24
$774.6M
$1.2B
Total Assets
KRO
KRO
SCL
SCL
Q1 26
$2.3B
Q4 25
$1.8B
$2.4B
Q3 25
$1.9B
$2.4B
Q2 25
$1.9B
$2.4B
Q1 25
$1.9B
$2.4B
Q4 24
$1.9B
$2.3B
Q3 24
$1.9B
$2.4B
Q2 24
$1.7B
$2.3B
Debt / Equity
KRO
KRO
SCL
SCL
Q1 26
0.28×
Q4 25
0.74×
0.50×
Q3 25
0.78×
0.53×
Q2 25
0.70×
0.53×
Q1 25
0.66×
0.55×
Q4 24
0.62×
0.53×
Q3 24
0.65×
0.56×
Q2 24
0.55×
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KRO
KRO
SCL
SCL
Operating Cash FlowLast quarter
$92.1M
Free Cash FlowOCF − Capex
$81.9M
FCF MarginFCF / Revenue
19.6%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KRO
KRO
SCL
SCL
Q1 26
Q4 25
$92.1M
$60.0M
Q3 25
$-7.9M
$69.8M
Q2 25
$20.7M
$11.2M
Q1 25
$-102.4M
$6.9M
Q4 24
$49.3M
$68.3M
Q3 24
$28.3M
$22.7M
Q2 24
$38.2M
$29.5M
Free Cash Flow
KRO
KRO
SCL
SCL
Q1 26
Q4 25
$81.9M
$25.4M
Q3 25
$-17.4M
$40.2M
Q2 25
$9.5M
$-14.4M
Q1 25
$-114.4M
$-25.8M
Q4 24
$37.0M
$32.1M
Q3 24
$19.2M
$-4.0M
Q2 24
$34.8M
$-208.0K
FCF Margin
KRO
KRO
SCL
SCL
Q1 26
Q4 25
19.6%
4.6%
Q3 25
-3.8%
6.8%
Q2 25
1.9%
-2.4%
Q1 25
-23.4%
-4.3%
Q4 24
8.7%
6.1%
Q3 24
4.0%
-0.7%
Q2 24
7.0%
-0.0%
Capex Intensity
KRO
KRO
SCL
SCL
Q1 26
Q4 25
2.4%
6.3%
Q3 25
2.1%
5.0%
Q2 25
2.3%
4.3%
Q1 25
2.4%
5.5%
Q4 24
2.9%
6.9%
Q3 24
1.9%
4.9%
Q2 24
0.7%
5.3%
Cash Conversion
KRO
KRO
SCL
SCL
Q1 26
Q4 25
11.99×
Q3 25
6.44×
Q2 25
0.99×
Q1 25
-5.66×
0.35×
Q4 24
20.38×
Q3 24
0.39×
0.96×
Q2 24
1.96×
3.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KRO
KRO

Segment breakdown not available.

SCL
SCL

Surfactants$453.7M75%
Polymers$130.0M22%
Specialty Products$20.8M3%

Related Comparisons